Skip to content

Budd-Chiari syndrome

Written and medically reviewed by Bahir Hadi, specialist in surgery, PhD

Published: 16 November 2026

Profile, experience and publications

Budd-Chiari Syndrome: When Blood Cannot Leave the Liver

Budd-Chiari syndrome is a rare condition where the large veins that drain blood from the liver become completely or partially blocked. Blood accumulates in the liver, putting pressure on liver cells and potentially leading to liver failure and portal hypertension over time. The literature describes the condition as rare (Plessier A, Valla DC. Budd-Chiari syndrome. Semin Liver Dis 2008;28(3):259-269, PubMed).

The disease was first described by the British physician George Budd in 1845 and later elaborated upon by pathologist Hans Chiari in 1899.

What are the symptoms?

Symptoms depend on how quickly blood flow is blocked.

Acute form (a few days to weeks):

  • Sudden, severe pain in the upper right side of the abdomen
  • Rapidly increasing fluid in the abdominal cavity (ascites)
  • Jaundice
  • Swollen, tender liver
  • Nausea and vomiting
  • In severe cases, liver failure with confusion

Chronic form (months to years):

  • Persistent abdominal fluid that returns despite diuretic medication
  • Swollen legs
  • Visible veins on the abdomen and chest (collateral circulation)
  • Bleeding varicose veins in the oesophagus
  • Enlarged spleen
  • Fatigue and weight loss

A small group experiences fulminant Budd-Chiari with acute liver failure over a few days, requiring an urgent liver transplant.

Why does it happen?

Many patients have an underlying condition that increases blood clotting:

  • Myeloproliferative diseases (especially polycythaemia vera and essential thrombocythaemia) – the most common cause, often associated with a JAK2 mutation
  • Antiphospholipid syndrome
  • Factor V Leiden and other inherited thrombophilias
  • Paroxysmal nocturnal haemoglobinuria
  • Pregnancy and oral contraceptives
  • Behçet's disease
  • Inflammatory bowel disease

Less commonly, the blockage is due to external pressure from a tumour (liver tumour, kidney tumour), webs in the inferior vena cava (common in Asia), or infections.

More than one risk factor can be present in the same patient. EASL therefore recommends systematic work-up for underlying prothrombotic conditions, organised by an expert centre [4].

How is the diagnosis made?

  • Doppler ultrasound of the liver: the first choice. Shows absent or reversed blood flow in the hepatic veins.
  • CT or MRI scan of the liver with contrast: confirms the diagnosis and maps the extent of the blockage.
  • Liver biopsy: may show centrilobular blood stasis and liver cell death, but is not always necessary.
  • Thrombophilia work-up and JAK2 mutation test to find the underlying cause.

Early diagnosis is crucial because treatment is more effective before irreversible liver damage occurs.

Treatment

Treatment follows a step-wise approach, where you move up a step if the previous one is not effective.

  1. Anticoagulation. In primary Budd-Chiari syndrome, EASL recommends that therapeutic anticoagulation is started as soon as possible after diagnosis and continued indefinitely unless contraindicated. The recommended regimen is low molecular weight heparin followed by a vitamin K antagonist. A DOAC may be considered as an alternative when liver function is preserved. Drug choice, monitoring and duration are set together with an expert centre based on the underlying cause, liver function and bleeding risk [4].
  2. Treatment of the underlying disease, e.g., hydroxyurea for polycythaemia vera.
  3. Endovascular treatment – angioplasty with or without stenting for short segment stenosis.
  4. TIPS (transjugular intrahepatic portosystemic shunt) – placement of an internal shunt between the portal vein and the hepatic vein. Considered when medical treatment alone is not sufficient.
  5. Liver transplantation for fulminant liver failure or lack of effect from TIPS.

Symptomatic treatment includes diuretics, salt restriction, treatment of oesophageal varices, and prevention of encephalopathy.

Prognosis

The course is individual and depends among other things on how early the diagnosis is made, whether there is a treatable underlying cause, and how the liver and the clots respond to treatment. Follow-up is planned at a liver unit.

When should you see a doctor?

Contact the acute medical helpline (1813 in the Capital Region of Denmark, otherwise your local out-of-hours doctor) straight away and ask for urgent hospital assessment for:

  • Sudden severe pain in the upper right side of the abdomen combined with rapidly increasing abdominal fluid
  • Jaundice that develops over a few days
  • Confusion in a patient with known liver disease

Call 112 for reduced consciousness, collapse or signs of circulatory collapse.

Consult your GP for slowly increasing abdominal fluid, swollen legs, fatigue, and unexplained elevated liver enzymes – especially if you have a known blood disorder, antiphospholipid syndrome, or are taking oral contraceptives.

Frequently asked questions

Is Budd-Chiari hereditary? The syndrome itself is not hereditary, but the underlying thrombophilias (e.g., Factor V Leiden, JAK2 mutation) can be.

Can you get Budd-Chiari without an underlying blood disorder? Yes, but it is rare. EASL therefore recommends that everyone with Budd-Chiari syndrome is investigated for an underlying prothrombotic condition, also after treatment has started [4]. The work-up is planned by an expert centre.

Do I need to take blood thinners for the rest of my life? In Budd-Chiari syndrome, EASL recommends that anticoagulation is continued indefinitely unless contraindicated. In practice that means treatment rarely has an end date agreed in advance, and the balance of benefit and bleeding risk is reassessed over time [4]. The choice of drug, the monitoring and any change belong at the expert centre following you. Never stop or change treatment on your own.

Can I become pregnant? Only after careful planning with specialists, because pregnancy increases the risk of new blood clots. EASL recommends that clinicians switch a vitamin K antagonist or a DOAC to low molecular weight heparin immediately after the pregnancy is confirmed and at the latest before week 4, and that heparin is continued throughout the pregnancy. The switch is a clinician-led decision made by your doctors [4]. Contact your specialist immediately if you are planning a pregnancy, suspect one or have had one confirmed. Never switch or stop the medicine on your own.

What is the difference between Budd-Chiari and sinusoidal obstruction syndrome? Budd-Chiari affects the large hepatic veins; sinusoidal obstruction syndrome affects the smallest veins within the liver tissue and is seen especially after bone marrow transplantation or certain cytotoxic drugs.

About the figures on this page: incidence, complication, recurrence and survival figures for rare diseases come from international series at specialist centres with relatively few patients, often across different time periods and using different definitions. The figures therefore vary between series and cannot be transferred directly to the individual patient.


References

  1. DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology. 2009;49(5):1729-1764. PubMed
  2. Plessier A, Valla DC. Budd-Chiari syndrome. Semin Liver Dis. 2008;28(3):259-269. PubMed
  3. Sundhed.dk. Budd-Chiari syndrom (lægehåndbogen).
  4. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on vascular diseases of the liver. J Hepatol. 2026;84(2):399-456. Epub 12 November 2025. DOI: 10.1016/j.jhep.2025.08.001. PubMed
  5. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: vascular diseases of the liver. J Hepatol. 2016;64(1):179-202 (previous edition). PubMed

This article provides general information and does not replace a medical consultation. Contact your GP if you experience symptoms.

Download article as PDF (in Danish)

More on this topic at Kirurgen.dk

Category: Rare and lesser-known gastrointestinal diseases

Related

Share this page